| Publication | Year | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Authors :
Sanjay Rao Gergal Gopalkrishna Rao
Journal : Cureus Journal Reference count : 9 |
2024 | ||||||||
|
Authors :
Sanjay Rao
Journal : Journal of Indian Association of Pediatric Surgeons Journal Reference count : 12 Volume : 27 Pages : 191-195 |
2022 | ||||||||
|
Pharmaceutical Portfolio Development: Strategic Rationale, Challenges & Solutions Authors : Sanjay K. RaoJournal : Journal of Commercial Biotechnology Volume : 27 |
2022 | ||||||||
|
R&D Spending & Success: Key Trends, Issues & Solutions Authors : Sanjay Kumar RaoJournal : Journal of Commercial Biotechnology Volume : 23 |
2017 | ||||||||
|
Trends in Market Access for Specialty Biologics: Challenges & Promises Authors : Sanjay Kumar RaoJournal : Journal of Commercial Biotechnology Volume : 21 |
2015 | ||||||||
|
A Patient Centric Commercial Model for Cancer Care Authors : Sanjay RaoJournal : Journal of Commercial Biotechnology Volume : 19 |
2013 | ||||||||
|
Generating growth through patient-centered commercial strategies Authors : Sanjay K RaoJournal : Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing Journal Reference count : 11 Volume : 12 Pages : 229-239 |
2012 | ||||||||
|
Reversibility of Dry Eye Deceleration After Topical Cyclosporine 0.05% Withdrawal Authors : Sanjay N. RaoJournal : Journal of Ocular Pharmacology and Therapeutics Journal Reference count : 26 Volume : 27 Pages : 603-609 |
2011 | ||||||||
|
Topical Cyclosporine 0.05% for the Prevention of Dry Eye Disease Progression Authors : Sanjay N. RaoJournal : Journal of Ocular Pharmacology and Therapeutics Journal Reference count : 34 Volume : 26 Pages : 157-164 |
2010 | ||||||||
|
Pricing biologics: Issues, strategic priorities and a conceptual model Authors : Sanjay K RaoJournal : Journal of Commercial Biotechnology Journal Reference count : 24 Volume : 17 Pages : 7-23 |
2010 | ||||||||
|
Rethinking commercial strategy – A patient-centered commercial model Authors : Sanjay K RaoJournal : Journal of Commercial Biotechnology Journal Reference count : 36 Volume : 16 Pages : 206-223 |
2010 | ||||||||
|
Re‐energizing a product portfolio: case study of a pharmaceutical merger Authors : Sanjay K. RaoJournal : Journal of Business Strategy Journal Reference count : 7 Volume : 30 Pages : 52-62 |
2009 | ||||||||
|
A new paradigm for developing bio/pharmaceutical positioning strategy Authors : Sanjay K RaoJournal : Journal of Medical Marketing Journal Reference count : 11 Volume : 9 Pages : 29-39 |
2008 | ||||||||
|
An innovative approach to developing and managing biopharmaceutical pricing strategy Authors : Sanjay K RaoJournal : Journal of Medical Marketing Journal Reference count : 6 Volume : 8 Pages : 94-100 |
2008 | ||||||||
|
Authors :
Sanjay N. Rao
Journal : American Journal of Ophthalmology Journal Reference count : 6 Volume : 141 Pages : 771-772 |
2006 | ||||||||
|
Pharmaceutical Product Portfolios Authors : Sanjay Kumar RaoJournal : Pharmaceutical Development and Regulation Journal Reference count : 11 Volume : 1 Pages : 91-100 |
2003 | ||||||||
|
Intralenticular Hemorrhage Following Blunt Ocular Trauma Authors : Sanjay N. RaoJournal : Archives of Ophthalmology Volume : 116 Pages : 1258 |
1998 | ||||||||
|
An Empirical Comparison of Sales Forecasting Models Authors : Sanjay‐kumar RaoJournal : Journal of Product Innovation Management Journal Reference count : 25 Volume : 2 Pages : 232-242 |
1985 | ||||||||
|
Rethinking commercial strategy – A patient-centered commercial model Authors : Sanjay K RaoJournal : Journal of Commercial Biotechnology Volume : 16 |
1969 | ||||||||
|
Pricing biologics: Issues, strategic priorities and a conceptual model Authors : Sanjay K RaoJournal : Journal of Commercial Biotechnology Volume : 17 |
1969 | ||||||||